Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
REDEFINE-1 trial dosing protocol Study design: Duration: 68 weeks Participants: Adults with obesity (BMI 30) Arms: CagriSema vs semaglutide 2.4mg vs placebo Pre-filled combination pen (not separate injections) Fixed-dose weekly administration Primary endpoint results: Key findings: 50% more weight loss than semaglutide alone Superior to either peptide used individually Synergistic not merely additive effect Higher side effect rate but manageable Most participants tolerated full doses Learn the science at SeekPeptides - explore what are peptides , how peptides work , and peptides for weight loss
When combined with exercise, this approach may significantly boost fat utilisation, as the body is primed to use fat for fuel
Now it's time for the practical application
These findings establish the mechanistic basis for the compound and provide proof of concept for its metabolic effects
US$ 28.91
US$ 22.16
US$ 25.39
US$ 22.71
US$ 27.89
US$ 23.40
US$ 29.60
US$ 24.30
